RUNX2 and osteosarcoma: RUNX2/RUNX2 thus has potential as a predictive biomarker for osteosarcoma, but a better understanding of the gene and protein in the context of the disease is necessary before considering targeted treatments and diagnostic, prognostic, and predictive tests.